Intuitive Surgical (ISRG) Stock Price, News & Analysis

+2.59 (+0.71%)
(As of 04/22/2024 ET)
Today's Range
50-Day Range
52-Week Range
1.60 million shs
Average Volume
1.67 million shs
Market Capitalization
$130.77 billion
P/E Ratio
Dividend Yield
Price Target

Intuitive Surgical MarketRank™ Stock Analysis

Analyst Rating
Moderate Buy
2.76 Rating Score
7.4% Upside
$396.17 Price Target
Short Interest
0.96% of Shares Sold Short
Dividend Strength
Upright™ Environmental Score
News Sentiment
0.84mentions of Intuitive Surgical in the last 14 days
Based on 47 Articles This Week
Insider Trading
Selling Shares
$95.93 M Sold Last Quarter
Proj. Earnings Growth
From $4.93 to $5.80 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

4.72 out of 5 stars

Medical Sector

63rd out of 910 stocks

Surgical Appliances & Supplies Industry

3rd out of 18 stocks

ISRG stock logo

About Intuitive Surgical Stock (NASDAQ:ISRG)

Intuitive Surgical, Inc. is a leading medical technology company specializing in robotic-assisted surgical systems. Founded in 1995, the company's mission is to improve patient outcomes through the use of innovative technology and minimally invasive surgical techniques. Headquartered in Sunnyvale, California, Intuitive Surgical operates globally, serving healthcare professionals and patients in over 60 countries.

Intuitive Surgical's flagship product is the da Vinci Surgical System, a robotic platform that enables surgeons to perform complex procedures with enhanced precision, control, and visualization. The system consists of robotic arms controlled by the surgeon, along with a high-definition 3D camera and specialized surgical instruments. This advanced technology allows for smaller incisions, reduced scarring, shorter recovery times, and improved clinical outcomes.

The company's target market primarily includes hospitals and surgical centers specializing in urology, gynecology, general, and thoracic surgery. Intuitive Surgical has established itself as a leader in these fields and has a strong customer base, including prestigious medical institutions and renowned surgeons. The company's dedication to innovation and patient care has garnered numerous accolades, including recognition as one of Fortune's "World's Most Admired Companies" in the healthcare industry.

Intuitive Surgical is led by an experienced management team committed to driving the company's growth and maintaining its position as a leader in surgical robotics. Dr. Gary Guthart is the Chief Executive Officer and has been instrumental in guiding the company's strategic direction. Under his leadership, Intuitive Surgical has expanded its product portfolio, entered new markets, and achieved remarkable financial success.

Intuitive Surgical has consistently delivered strong financial performance over the past few years. The company's revenue has experienced steady growth, reaching $6.22 billion in the latest fiscal year. With a strong focus on operational efficiency, Intuitive Surgical has maintained healthy profit margins, enabling it to invest in research and development and expand its market reach.

The company has a solid balance sheet with manageable debt levels. This provides stability and financial flexibility for future investments and acquisitions. Intuitive Surgical's financial performance is notably impressive compared to industry benchmarks, reflecting its strong market position and competitive advantage.

Intuitive Surgical commands a premium compared to its industry peers. The company's price-to-earnings ratio, a commonly used valuation measure, is higher than average due to its strong growth prospects and dominant market position. Investors have recognized the company's innovation and potential for long-term success, contributing to its higher valuation.

Intuitive Surgical has exhibited remarkable stock performance in recent years. The company's share price has experienced significant growth, reflecting investor confidence in its business model and growth potential. Notably, the stock has outperformed broader market indices and many of its industry peers.

Intuitive Surgical operates in the rapidly evolving field of surgical robotics, which is transforming the healthcare landscape. The industry is characterized by intense competition, with major players including Medtronic, Johnson & Johnson, and Stryker Corporation. These companies continually invest in research and development to enhance their robotic surgical systems and expand their market presence.

Regulatory and political factors also play a significant role in the industry. Government agencies, such as the U.S. Food and Drug Administration (FDA), regulate the approval and safety of robotic surgical systems. Changes in regulations or introducing new policies can impact the industry landscape and market access for companies like Intuitive Surgical.

Despite the competitive landscape, Intuitive Surgical maintains a solid competitive advantage. The company's pioneering da Vinci Surgical System has established a dominant position in the market, with a large installed base worldwide. This gives Intuitive Surgical a significant edge in terms of customer loyalty and brand recognition. Additionally, the company's focus on continuous innovation and product development enables it to stay ahead of the competition.

Acquisitions and strategic partnerships offer growth opportunities for Intuitive Surgical. The company has a strong balance sheet enabling it to pursue strategic acquisitions that complement its existing product portfolio or provide access to new markets. Collaborating with other medical technology companies or research institutions can also fuel innovation and open doors to novel surgical solutions.

Like any company operating in the healthcare industry, Intuitive Surgical faces various risks and challenges. One significant risk is the potential for changes in healthcare policies and reimbursement rates. Government policies can directly impact the adoption and utilization of robotic surgical systems, which could affect the demand for Intuitive Surgical's products.

Another challenge is emerging new technologies or surgical techniques that may compete with or disrupt the robotic-assisted surgery market. Technological advancements in artificial intelligence and virtual reality could offer alternative solutions to traditional surgical procedures. Intuitive Surgical must stay at the forefront of innovation and adapt its offerings to remain competitive.

Additionally, the company faces the risk of product recalls or safety concerns. As robotic surgical systems become more complex, ensuring their reliability and patient safety becomes paramount. Intuitive Surgical must continue to invest in quality control measures, regulatory compliance, and ongoing training for surgeons to mitigate these risks.

ISRG Stock Price History

ISRG Stock News Headlines

Intuitive Surgical Leads the Robotic Surgery Movement
While artificial intelligence (AI) and robots are in the spotlight regularly these days, there's a company that's been making surgical robots for over two decades. Intuitive Surgical Inc. NASDAQ: ISRG is the pioneer in robotic-assisted surgical systems.
Intuitive Surgical Leads the Robotic Surgery Movement
Intuitive Surgical is the pioneer in robotic-assisted surgery, investors hope the fifth generation of its da Vinci system can push ISRG stock higher
Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Intuitive Surgical Stock Can Trend Much Higher This Year
If you wonder if Intuitive Surgical NASDAQ: ISRG stock can trend higher this year, it can. The med tech business is growing, and Intuitive Surgical is the industry leader and outperforming expectations.
Intuitive Surgical Stock Can Trend Much Higher This Year 
Intuitive Surgical is the leading medtech. It outpaces industry growth and analysts' expectations. Cash flow is solid and improves shareholder value.
Johnson & Johnson is as Cheap as it’s Going to Get (ISRG)
Johnson & Johnson raised its dividend for the 62nd consecutive year and has the power to continue raising the annual payout indefinitely.
Incredible Opportunity to Retire FAST!
A brand-new guide from the host of one of the world's largest cryptocurrency podcasts lays out an action plan that could help you retire quickly and comfortably in today's crypto market.
Intuitive Surgical (NASDAQ:ISRG) PT Raised to $435.00
Intuitive Surgical (NASDAQ:ISRG) PT Raised to $375.00
See More Headlines
Receive ISRG Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Intuitive Surgical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
Next Earnings (Estimated)
Fiscal Year End

Industry, Sector and Symbol

Surgical appliances & supplies
Health Care Equipment
Current Symbol
Year Founded

Price Target and Rating

Average Stock Price Target
High Stock Price Target
Low Stock Price Target
Potential Upside/Downside
Consensus Rating
Moderate Buy
Rating Score (0-4)
Research Coverage
17 Analysts


Net Income
$1.80 billion
Pretax Margin


Sales & Book Value

Annual Sales
$7.12 billion
Cash Flow
$5.50 per share
Book Value
$38.03 per share


Free Float
Market Cap
$131.61 billion

Social Links

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Should I Buy Intuitive Surgical Stock? ISRG Pros and Cons Explained


Here are some ways that investors could benefit from investing in Intuitive Surgical, Inc.:

  • Intuitive Surgical, Inc. has been consistently innovating in the field of minimally invasive care, particularly with their latest products like the da Vinci Surgical System and Ion endoluminal system.
  • The company's focus on enhancing the quality of healthcare through minimally invasive procedures aligns with the growing trend towards less invasive medical treatments.
  • Intuitive Surgical's strong market presence and reputation for cutting-edge technology could provide stability and growth potential for investors.
  • Recent positive analyst ratings and institutional investor holdings indicate confidence in the company's future performance.
  • Considering the current stock price and potential for growth in the medical sector, investing in Intuitive Surgical could offer a promising return on investment.


Investors should be bearish about investing in Intuitive Surgical, Inc. for these reasons:

  • Market competition in the medical device industry is intense, which could impact Intuitive Surgical's market share and profitability.
  • Regulatory challenges and changes in healthcare policies could affect the company's product approvals and market access.
  • The reliance on a few key products, such as the da Vinci Surgical System, poses a risk in case of technological advancements by competitors.
  • Fluctuations in healthcare spending and economic conditions may influence demand for Intuitive Surgical's products and services.
  • Investors should carefully consider the potential risks associated with investing in a specialized medical technology company like Intuitive Surgical.
These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Wednesday, April 10, 2024. Please send any questions or comments about these Intuitive Surgical pros and cons to

ISRG Stock Analysis - Frequently Asked Questions

Should I buy or sell Intuitive Surgical stock right now?

17 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Intuitive Surgical in the last twelve months. There are currently 4 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" ISRG shares.
View ISRG analyst ratings
or view top-rated stocks.

What is Intuitive Surgical's stock price target for 2024?

17 brokers have issued 1 year price objectives for Intuitive Surgical's stock. Their ISRG share price targets range from $314.00 to $462.00. On average, they expect the company's share price to reach $396.17 in the next twelve months. This suggests a possible upside of 7.4% from the stock's current price.
View analysts price targets for ISRG
or view top-rated stocks among Wall Street analysts.

How have ISRG shares performed in 2024?

Intuitive Surgical's stock was trading at $337.36 at the start of the year. Since then, ISRG stock has increased by 9.4% and is now trading at $368.93.
View the best growth stocks for 2024 here

When is Intuitive Surgical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, July 18th 2024.
View our ISRG earnings forecast

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) posted its quarterly earnings results on Thursday, April, 18th. The medical equipment provider reported $1.50 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.40 by $0.10. The medical equipment provider earned $1.89 billion during the quarter, compared to the consensus estimate of $1.87 billion. Intuitive Surgical had a trailing twelve-month return on equity of 12.91% and a net margin of 27.16%. Intuitive Surgical's quarterly revenue was up 11.5% compared to the same quarter last year. During the same quarter in the previous year, the business posted $1.00 earnings per share.
Read the conference call transcript

When did Intuitive Surgical's stock split?

Intuitive Surgical's stock split on Tuesday, October 5th 2021. The 3-1 split was announced on Thursday, August 5th 2021. The newly created shares were payable to shareholders after the closing bell on Monday, October 4th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

What is Gary S. Guthart's approval rating as Intuitive Surgical's CEO?

431 employees have rated Intuitive Surgical Chief Executive Officer Gary S. Guthart on Gary S. Guthart has an approval rating of 99% among the company's employees. This puts Gary S. Guthart in the top 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Intuitive Surgical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Intuitive Surgical investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), Tesla (TSLA), Salesforce (CRM), PayPal (PYPL), Walt Disney (DIS), Boeing (BA), Mastercard (MA) and Adobe (ADBE).

Who are Intuitive Surgical's major shareholders?

Intuitive Surgical's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Sumitomo Mitsui Trust Holdings Inc. (0.41%), Allspring Global Investments Holdings LLC (0.13%), Raymond James & Associates (0.09%), Congress Asset Management Co. MA (0.08%), State of Michigan Retirement System (0.06%) and Wealth Enhancement Advisory Services LLC (0.04%). Insiders that own company stock include Alan J Levy, Amal M Johnson, Amy L Ladd, Craig H Barratt, Craig H Barratt, Curet Myriam, David J Rosa, David J Rosa, Fredrik Widman, Gary S Guthart, Jamie Samath, Keith R Leonard, Mark Brosius, Mark J Rubash, Mark J Rubash, Marshall Mohr, Myriam Curet, Reiter Kara Andersen and Robert Desantis.
View institutional ownership trends

How do I buy shares of Intuitive Surgical?

Shares of ISRG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Intuitive Surgical have any subsidiaries?
The following companies are subsidiares of Intuitive Surgical: Computer Motion, Intuitive Surgical AB, Intuitive Surgical ApS, Intuitive Surgical Australia Proprietary Limited, Intuitive Surgical BV, Intuitive Surgical Brasil Importacao E Comercio De Equipamentos Cirurgicos Ltda, Intuitive Surgical Canada Inc, Intuitive Surgical Deutschland GmbH, Intuitive Surgical Fosun HongKong Co Ltd, Intuitive Surgical Fosun Medical Technology Shanghai Co Ltd, Intuitive Surgical GK, Intuitive Surgical HK Limited, Intuitive Surgical Holdings LLC, Intuitive Surgical India Private Limited, Intuitive Surgical International BV, Intuitive Surgical International Finance LLC, Intuitive Surgical Ireland Limited, Intuitive Surgical Israel Ltd, Intuitive Surgical Korea Limited, Intuitive Surgical Limited, Intuitive Surgical Medical Device Science & Technology Shanghai Co Ltd, Intuitive Surgical Medical Device Taiwan Ltd, Intuitive Surgical Operations Inc, Intuitive Surgical Optics Gmbh, Intuitive Surgical Pte Ltd, Intuitive Surgical S de R L de CV, Intuitive Surgical SAS, Intuitive Surgical SPRL, Intuitive Surgical Sarl, Intuitive Surgical Sarl Taiwan Branch, Intuitive Surgical Service Optics Inc, Intuitive Surgical Spain SL, Intuitive Surgical Turkey Medikal Cihaz Ticaret Limited Serketi, Intuitive Surgical sro, Intuitive Ventures Fund I LLC, NeoGuide Systems, Orpheus Medical, Orpheus Medical Gmbh, Orpheus Medical Inc, Orpheus Medical Ltd, Orpheus Medical USA Inc, and Scholly Micro Optics Gmbh.
Read More
This page (NASDAQ:ISRG) was last updated on 4/22/2024 by Staff

From Our Partners